Clinical Trials Logo

Metastatic Brain Cancer clinical trials

View clinical trials related to Metastatic Brain Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT05559853 Recruiting - Brain Metastases Clinical Trials

Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

Start date: September 22, 2022
Phase:
Study type: Observational

The purpose of this study is to develop and test a new magnetic resonance imaging (MRI) technique to see if it can be used to tell the difference between tumor growth from worsening of cancer and growth from the effects of treatment in participants who have brain tumors treated with radiation therapy called stereotactic radiosurgery (SRS).

NCT ID: NCT03721055 Recruiting - Cancer Clinical Trials

Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

Start date: August 21, 2017
Phase: N/A
Study type: Interventional

This clinical trial studies positron emission tomography (PET) imaging utilizing 18F-(2S,4R)4-fluoroglutamine, a glutamic acid derivative, to image patients with malignant tumor. [18F]Fluoroglutamine PET may provide additional information that help diagnose and stage cancer patients.

NCT ID: NCT02213536 Terminated - Clinical trials for Metastatic Brain Cancer

Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain.

SPARE
Start date: August 2015
Phase:
Study type: Observational

To investigate the use of a scalp sparing technique of radiotherapy treatment designed to treat the whole brain. Current treatment methods to treat the whole brain with radiotherapy result in complete alopecia as a side effect. Hair loss is usually patchy and uneven and re-growth similar and slow. It is hoped that reducing the radiation dose to the hair bearing follicle on the scalp will reduce hair loss and increase the speed and evenness of re-growth.

NCT ID: NCT01890278 Recruiting - Clinical trials for Metastatic Brain Cancer

Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases

Start date: June 2013
Phase: N/A
Study type: Interventional

In this study the patient will receive either whole brain radiation therapy given by intensity modulated radiation therapy (IMRT) or standard conventional radiation. In IMRT therapy radiation dose to the parts of the brain that do not contain tumors is reduced. This study will look to see if this approach results in less hair loss or fewer memory Problems, as compared to the standard technique. The study will also look at the effectiveness of both techniques in controlling the growth of the tumor.

NCT ID: NCT01473485 Active, not recruiting - Glioma Clinical Trials

ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors

Start date: April 2011
Phase: N/A
Study type: Interventional

A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors

NCT ID: NCT00610285 Completed - Clinical trials for Metastatic Brain Cancer

A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases

Start date: October 2005
Phase: N/A
Study type: Observational

Stereotactic radiosurgery (SRS) is a way to accurately treat brain tumors. SRS involves the use of a special head frame to keep the head from moving during treatment. The head frame makes very accurate treatment possible. The frame must be attached to the skull with special pins. It feels very tight and can hurt. A special immobilization device can be used to keep the head from moving. This device does not need any pins and does not hurt. We would like to see if the new way of holding the head still can be used for SRS. This is the purpose of the study. New X-Ray machines can be used to find if the head has moved in the mask. We hope that we can use these new tools to treat brain tumors just as accurately without using a head frame. It will make treatment more comfortable for the patient. This is why we are asking patients to join the study.

NCT ID: NCT00525590 Completed - Clinical trials for Metastatic Brain Cancer

Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

Start date: December 12, 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of the surgical intervention and insertion of GLIADEL wafers on the neurocognitive functioning in patients with metastatic brain cancer.